NCT05987189 - Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung | Biotech Hunter

Enrollment

2,000

Participants

Timeline

Start Date

October 18, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2025

Conditions

Lung Cancer

Interventions

DIAGNOSTIC_TEST

miLungDx

At study enrollment a blood sample will be drawn prior to any invasive diagnostic study or treatment. On this blood sample a novel lung cancer test relying on small RNA signatures will be performed and evaluated.

Trial Locations (8)

10461

RECRUITING

Jacobi Medical Center, The Bronx

RECRUITING

New York Health + Hospitals, The Bronx

27710

RECRUITING

Duke University Health System, Durham

30342

RECRUITING

Northside Hospital, Atlanta

48202

RECRUITING

Henry Ford Health, Detroit

77701

RECRUITING

Baptist Hospitals of Southeast Texas, Beaumont

84112

RECRUITING

University Of Utah Health, Salt Lake City

02115

RECRUITING

Mass General Brigham, Boston